Transvenous lead extraction – current indications Review article
Article Sidebar
Main Article Content
Abstract
From 60’s number of implantations of cardiovascular implantable electronic devices (CIED) grows systematically. With rising number of active CIEDs, there is growth in number of complications, non functioning electrodes, and upgrade indications. Accumulative clinical issue are CIED infections, which can be vicious for patients health and life. In a consequence in last few years we can see progressive role of transvenous lead extraction, as a effective and relatively safe kind of treatment. In 2009 and 2010 American and European societies of cardiology released guidelines concerning the treatment of CIED infections and indications to lead extractions. Common element of these publications \are indications to transvenous lead extractions, which systematization will be a subject of this article.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright: © Medical Education sp. z o.o. This is an Open Access article distributed under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)
References
2. Wilkoff B.L., Love C.J., Byrd, C.L. et al.: Transvenous Lead Extraction: Heart Rhythm Society Expert Consensus on Facilities, Training, Indications, and Patient Management. Heart Rhythm 2009; 6(7): 1085-104.
3. Baddour L.M., Epstein A.E., Erickson C.C. et al.: Update on Cardiovascular Implantable Electronic Device Infections and Their Management : A Scientific Statement From the American Heart Association. Circulation 2010; 121(3): 458-77.
4. Uslan D.Z., Sohail M.R., St Sauver J.L. et al.: Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch. Intern. Med. 2007; 167(7): 669-75.
5. Habib G., Hoen B., Tornos P. et al.: Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009). Eur. Heart J. 2009; 30: 2369-2413.
6. Małecka B., Kutarski A.: Lead-dependent infective endocarditis: an old problem, a new name. Cardiol. J. 2010; 17(2): 205-10.
7. Brignole M., Auricchio A., Baron-Esquivias G. et al.: 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur. Heart J. 2013; 34: 2281-2329.
8. Bongiorni M.G., Blomström-Lundqvist C., Kennergren C.: Current practice in transvenous lead extraction: a European Heart Rhythm Association EP Network Survey. Europace 2012; 14: 783-786.
9. Wilkoff B.L., Byrd C.L., Love C.J. et al.: Trends in intravascular lead extraction: analysis of data from 5339 procedures in 10 years. XIth World Symposium on Cardiac Pacing and Electrophysiology, Berlin. Pacing Clin. Electrophysiol. 1999; 22(Pt II): A207.